Bayer inks Cedilla cancer deal to join pack chasing Pfizer
01 Jun 2023 //
FIERCE BIOTECH
Bayer to acquire exclusive license from Cedilla Therapeutics
01 Jun 2023 //
BUSINESSWIRE
Third Rock shrinks another biotech as Cedilla restructures, CEO and CBO depart
23 Feb 2023 //
ENDPTS
Cedilla adds $25M to series B to test two cancer drugs in trials
26 Oct 2021 //
FIERCEBIOTECH
Cedilla Unveils Lead Programs for Conditional Inhibition of TEAD & CDK2
21 Oct 2021 //
BIOSPACE
Cedilla and HitGen Announce Research Collaboration Focused on DNA-Encoded
30 Nov 2020 //
BUSINESSWIRE